Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- ENPH -25.1% (announces restructuring/cost reduction initiatives resulting in about $20 mln in annualized savings; reaffirms Q3 & announces Q4 guidance)
Select financial related names showing weakness: SAN -3.5%, RBS -2.5%, LYG -2%, DB -1.7%, NMR -1.7%, CS -1.6%,HSBC -1.5%, BBVA -1.3%, PUK -1.1%
Other news:
Other news:
- CATB -14% (prices 2.5 mln common stock offering at $4.00/share)
- APRI -10.3% (announces $4.6 mln registered direct offering: 13.1 mln shares at $0.35/share)
- IPCI -9% (responds to recent trading activity, says not aware of any corporate developments that would cause the recent movement in the Company's share price)
- CAFD -5% (prices 7 mln Class A shares at $14.65 per share)
- LNTH -3.2% (anounces that new data from a sub-analysis of its first Phase 3 study of flurpiridaz F 18 for myocardial perfusion imaging in patients undergoing exercise stress testing will be presented at the 21st Annual Scientific Session of the ASNC)
- TM -2.4% (still checking)
- FB -2.2% (Ad buyers upset with FB for overestimating video average viewing time, according to WSJ)
- YHOO -1.7% (continued weakness after confirmed that a copy of certain user account information was stolen from the company's network in late 2014)
- HMHC -1.4% (President and CEO Linda K. Zecher resigns; co guides billings at or near the low end ofits revised guidance of $1,525 million to $1,595 million for 2016 )
Analyst comments:
- TWTR -3.9% (downgraded to Underperform at RBC Capita)
- CPTA -3.6% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities)
- WIX -2.5% (downgraded to Sector Perform at RBC Capital Mkts)
- BDX -1.5% (downgraded to Sell from Neutral at Citigroup)